Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats
- 6 December 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 60 (3) , 173-179
- https://doi.org/10.1016/s0024-3205(96)00613-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*Clinical Pharmacology & Therapeutics, 1995
- The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1995
- Disposition of intravenous and oral cyclosporine after administration with grapefruit juice*Clinical Pharmacology & Therapeutics, 1995
- Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionClinical Pharmacology & Therapeutics, 1992
- First-pass metabolism of cyclosporin by the gutThe Lancet, 1991
- Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantationThe American Journal of Cardiology, 1990
- Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugsClinical Pharmacology & Therapeutics, 1988
- Erythromycin enhances the absorption of cyclosporin.British Journal of Clinical Pharmacology, 1988
- Mode of Action of Probucol in Reducing Serum Cholesterol in MiceThe Japanese Journal of Pharmacology, 1986
- Metabolic studies with probucol in hypercholesterolaemiaAtherosclerosis, 1981